Welcome To Cellens
Sensing Cancer
on a Nanoscale Level
Bringing clarity and precision to cancer diagnostics through mechanobiology and machine learning
WHAT WE ARE DOING
Touching cancer cells with a nanoscale finger
Cellens is pioneering a novel diagnostic modality based on single cell biophysical markers. By touching cells at the nanoscale level, we uncover unique physical fingerprints of cancer cells that are ideal for accurate and non-invasive cancer detection.
A NONINVASIVE, URINE-BASED CANCER DIAGNOSTICS PLATFORM
Octosense Platform
Cellens platform is scalable and applicable to different types of cancer cells, extracted from bodily fluid to detect various clinical conditions. Our peer-reviewed, preliminary data highlights the superior performance of our platform to achieve high accuracy in detecting bladder cancer.
1. Proprietary Cell Fixation
2. Urine Sample Processing
3. Cell Surface Scanning
4. Machine Learning Analysis
WHO WE ARE
Meet the Cellens Team
We know what it takes to bring physical touch to cancer diagnostics.
Our team brings expertise in mechanobiology, mechanical engineering, and innovation commercialization, and we are supported by an extensive network of scientific and industry advisors.
WHO WE ARE
Our Specialties
Cellens is pioneering in label-free cell analysis with a combination of high-resolution nanoscale imaging and proprietary machine learning. Our novel application of quantitative cell’s
Bio-Related Research
Bio-Related Research
Bio-Related Research
Bio-Related Research
WHO WE ARE
Our Partners
